+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Panel Market - Global Forecast 2026-2032- Product Image
Gene Panel Market - Global Forecast 2026-2032- Product Image
Sale

Gene Panel Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887711
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gene Panel Market is projected to reach USD 4.18 Billion in 2026. It is expected to continue growing at a CAGR of 11.08%, reaching USD 7.88 Billion by 2032.

Gene Panels: Executive Overview

Gene panels are targeted sets of genetic markers analyzed together to support research, diagnosis, risk assessment, and treatment selection. Their value derives from combining focused biological scope with the ability to examine multiple genes efficiently, helping users investigate defined disease pathways, inherited conditions, tumor characteristics, or pharmacogenomic traits. Adoption is shaped by analytical validity, clinical utility, laboratory capability, reimbursement, regulation, data interpretation, and the quality of supporting evidence.

How Precision Genomics Is Reshaping Gene Panel Use

Gene panel workflows are shifting from narrowly defined assays toward more adaptable designs that can accommodate emerging biomarkers, updated variant knowledge, and different sample types. Laboratories increasingly evaluate panels not only on the number of genes covered, but also on coverage uniformity, limit of detection, turnaround time, reproducibility, workflow integration, and the interpretability of results. Standardization, quality assurance, consent practices, and secure handling of genomic information remain central as testing moves across clinical, translational, and research settings.

Artificial Intelligence Strengthens Interpretation and Workflow Efficiency

Artificial intelligence can support gene-panel workflows by prioritizing variants, linking findings with curated evidence, identifying patterns across clinical and molecular data, and assisting report generation. These applications may reduce manual review burden and improve consistency, but their usefulness depends on representative training data, transparent validation, human oversight, and clear accountability. Bias, false positives, explainability, cybersecurity, and protection of sensitive genomic information require explicit governance before AI-assisted outputs influence clinical decisions.

Regional Perspectives Across Global Gene-Panel Adoption

North America combines advanced sequencing infrastructure, specialized laboratories, and active precision-medicine programs, while reimbursement and regulatory requirements influence practical deployment. Europe’s adoption is shaped by coordinated research networks, national health systems, data-protection obligations, and differing implementation pathways across countries. Asia-Pacific includes highly developed genomics ecosystems alongside rapidly expanding laboratory capacity, with access, workforce, and regulatory harmonization remaining important considerations. Latin America is advancing through academic, public-health, and private laboratory initiatives, although infrastructure and affordability vary. In the Middle East, genomics programs and inherited-disease priorities support targeted testing, while implementation depends on specialist capacity and governance. Africa presents substantial opportunities for population-relevant genomics, with investment in infrastructure, locally representative reference data, training, and equitable access being especially important.

How ASEAN, BRICS, EU, G7, GCC, and NATO Contexts Differ

ASEAN markets reflect varied healthcare systems, laboratory maturity, and regulatory approaches, making interoperability and workforce development important enablers. BRICS members bring large and diverse populations, strong research potential, and differing capabilities in sequencing, reimbursement, and data governance. The European Union emphasizes cross-border health-data principles, quality standards, and privacy safeguards, while the G7 includes mature research and clinical ecosystems that can influence evidence and regulatory practices. GCC countries are developing genomics capacity through coordinated healthcare and national development initiatives, with attention to inherited disease and population health. NATO members span diverse health systems, but shared interests in biomedical resilience, secure data infrastructure, and research collaboration can support responsible genomic capability.

Country-Level Gene-Panel Priorities Across 15 Markets

Australia and Canada benefit from established research institutions and geographically dispersed healthcare needs that increase the importance of centralized expertise and equitable access. Brazil, Mexico, India, and Russia face varied regional capacity and affordability considerations while developing domestic genomics capability. China, Japan, and South Korea combine substantial scientific capacity with distinct regulatory, reimbursement, and data-governance environments. France, Germany, Italy, Spain, and the United Kingdom are supported by strong clinical and research infrastructures, with implementation influenced by national health-system processes, evidence requirements, and privacy rules. Across the United States, broad laboratory capability and precision-medicine activity coexist with complex payer, regulatory, and data-management considerations.

Practical Priorities for Gene-Panel Leaders

Industry leaders should define each panel around a documented clinical or research use case, then validate analytical performance with representative specimens and relevant controls. They should maintain transparent variant-interpretation procedures, regularly update knowledge resources, and provide reports that distinguish established findings from uncertain results. Investment in interoperable systems, trained genetic counselors and laboratory professionals, cybersecurity, consent management, and post-test support can improve responsible adoption. Leaders should also build evidence through collaborative studies, monitor real-world performance, engage regulators and payers early, and use AI only within audited, human-supervised workflows.

Methodology for the Gene-Panel Executive Summary

This summary uses a qualitative market-structure approach based on the supplied gene-panel scope and the specified regional, group, and country frameworks. It synthesizes established considerations affecting adoption, including technology performance, clinical utility, laboratory operations, regulation, reimbursement, workforce, data governance, and equity. The assessment deliberately avoids market estimates, market shares, forecasts, and company-specific claims. Regional and country observations are framed as contextual comparisons rather than ranked measurements, and conclusions should be supplemented with current primary research, regulatory documentation, clinical guidelines, and validated laboratory evidence.

Building Trustworthy and Actionable Gene-Panel Ecosystems

Gene panels remain valuable when their design is aligned with a clearly defined decision or research question and when results are supported by robust validation and interpretation. The next stage of development will depend less on breadth alone and more on evidence quality, workflow integration, responsible AI, secure data practices, and equitable access. Organizations that combine technical rigor with transparent governance and sustained clinical or research engagement will be better positioned to translate targeted genomic information into dependable outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gene Panel Market, by Product Type
7.1. Introduction
7.2. Somatic Gene Panels
7.2.1. Solid Tumor Panels
7.2.2. Hematological Malignancy Panels
7.3. Germline Gene Panels
7.3.1. Hereditary Cancer Panels
7.3.2. Cardiovascular Disease Panels
7.4. Carrier Screening Panels
8. Gene Panel Market, by Technology
8.1. Introduction
8.2. Microarray
8.2.1. Comparative Genomic Hybridization Arrays
8.2.2. Snp Arrays
8.3. NGS
8.3.1. Amplicon Sequencing
8.3.2. Hybrid Capture Sequencing
8.4. PCR
8.5. Sanger Sequencing Based Panels
9. Gene Panel Market, by Application
9.1. Introduction
9.2. Infectious Diseases
9.2.1. Bacterial Panels
9.2.2. Viral Panels
9.3. Oncology
9.3.1. Liquid Biopsy Panels
9.3.2. Solid Tumor Panels
9.4. Pharmacogenomics
9.5. Rare Diseases
9.5.1. Inherited Disease Panels
9.5.2. Neurological Disorder Panels
10. Gene Panel Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Diagnostic Laboratories
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotechnology Companies
11. Gene Panel Market, by Sales Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Gene Panel Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Gene Panel Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Gene Panel Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 10x Genomics, Inc.
16.2. Abbott Laboratories
16.3. Agilent Technologies, Inc.
16.4. Azenta, Inc.
16.5. BGI Genomics Co., Ltd.
16.6. Bio-Rad Laboratories, Inc.
16.7. Color Health, Inc.
16.8. Element Biosciences, Inc.
16.9. Eurofins Scientific SE
16.10. F. Hoffmann-La Roche AG
16.11. Fulgent Genetics, Inc.
16.12. GeneDx Holdings Corp.
16.13. Guardant Health, Inc.
16.14. Illumina, Inc.
16.15. Macrogen, Inc.
16.16. MedGenome Labs Pvt. Ltd.
16.17. Merck KGaA
16.18. Myriad Genetics, Inc.
16.19. Natera, Inc.
16.20. NeoGenomics Laboratories, Inc.
16.21. Oxford Nanopore Technologies plc
16.22. Pacific Biosciences of California, Inc.
16.23. Qiagen N.V.
16.24. Thermo Fisher Scientific Inc.
16.25. Twist Bioscience Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gene Panel Market, Years Considered for the Study
FIGURE 2. Global Gene Panel Market, Research Design
FIGURE 3. Global Gene Panel Market, Research Framework
FIGURE 4. Global Gene Panel Market, Data Triangulation
FIGURE 5. Global Gene Panel Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gene Panel Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Gene Panel Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gene Panel Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Gene Panel Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gene Panel Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Gene Panel Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gene Panel Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Gene Panel Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gene Panel Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 15. Global Gene Panel Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Gene Panel Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Gene Panel Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Gene Panel Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Gene Panel Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Gene Panel Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Gene Panel Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gene Panel Market Segmentation & Coverage
TABLE 2. Global Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Somatic Gene Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Somatic Gene Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Somatic Gene Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Solid Tumor Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Solid Tumor Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Solid Tumor Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Hematological Malignancy Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Hematological Malignancy Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Hematological Malignancy Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Germline Gene Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Germline Gene Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Germline Gene Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Hereditary Cancer Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Hereditary Cancer Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Hereditary Cancer Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Cardiovascular Disease Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Cardiovascular Disease Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Cardiovascular Disease Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Carrier Screening Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Carrier Screening Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Carrier Screening Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 26. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Comparative Genomic Hybridization Arrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Comparative Genomic Hybridization Arrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Comparative Genomic Hybridization Arrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Snp Arrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Snp Arrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Snp Arrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global NGS Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global NGS Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global NGS Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Amplicon Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Amplicon Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Amplicon Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Hybrid Capture Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Hybrid Capture Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Hybrid Capture Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Sanger Sequencing Based Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Sanger Sequencing Based Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Sanger Sequencing Based Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 51. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Bacterial Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Bacterial Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Bacterial Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Viral Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Viral Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Viral Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Liquid Biopsy Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Liquid Biopsy Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Liquid Biopsy Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Solid Tumor Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Solid Tumor Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Solid Tumor Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Pharmacogenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Pharmacogenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Pharmacogenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Rare Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Rare Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Rare Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Inherited Disease Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Inherited Disease Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Inherited Disease Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Neurological Disorder Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Neurological Disorder Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Neurological Disorder Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 95. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Gene Panel Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Gene Panel Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 115. North America Gene Panel Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. North America Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. North America Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 118. North America Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 119. North America Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 120. North America Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 121. North America Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 122. North America Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. North America Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 124. North America Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 125. North America Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 126. North America Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. North America Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 128. Latin America Gene Panel Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Latin America Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. Latin America Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 131. Latin America Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 132. Latin America Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 133. Latin America Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 134. Latin America Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 135. Latin America Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Latin America Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 137. Latin America Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 138. Latin America Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 139. Latin America Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Latin America Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 141. Europe Gene Panel Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Europe Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. Europe Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 144. Europe Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 145. Europe Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 146. Europe Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 147. Europe Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 148. Europe Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. Europe Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 150. Europe Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 151. Europe Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 152. Europe Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Europe Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 154. Middle East Gene Panel Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Middle East Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. Middle East Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 157. Middle East Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 158. Middle East Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. Middle East Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 160. Middle East Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 161. Middle East Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Middle East Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 163. Middle East Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 164. Middle East Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 165. Middle East Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Middle East Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 167. Africa Gene Panel Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Africa Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Africa Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 170. Africa Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 171. Africa Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 172. Africa Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 173. Africa Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 174. Africa Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Africa Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 176. Africa Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 177. Africa Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 178. Africa Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Africa Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 180. Global Gene Panel Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. ASEAN Gene Panel Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. ASEAN Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. ASEAN Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 184. ASEAN Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 185. ASEAN Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 186. ASEAN Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 187. ASEAN Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 188. ASEAN Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. ASEAN Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 190. ASEAN Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 191. ASEAN Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 192. ASEAN Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. ASEAN Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 194. GCC Gene Panel Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. GCC Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. GCC Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 197. GCC Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 198. GCC Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 199. GCC Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 200. GCC Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 201. GCC Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. GCC Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 203. GCC Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 204. GCC Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 205. GCC Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. GCC Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 207. European Union Gene Panel Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. European Union Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. European Union Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 210. European Union Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 211. European Union Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 212. European Union Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 213. European Union Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 214. European Union Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. European Union Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 216. European Union Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 217. European Union Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 218. European Union Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. European Union Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 220. BRICS Gene Panel Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. BRICS Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. BRICS Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 223. BRICS Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 224. BRICS Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 225. BRICS Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 226. BRICS Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 227. BRICS Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. BRICS Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 229. BRICS Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 230. BRICS Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 231. BRICS Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. BRICS Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 233. G7 Gene Panel Market Size, by Group, 2017-2032 (USD Million)
TABLE 234. G7 Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. G7 Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 236. G7 Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 237. G7 Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. G7 Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 239. G7 Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 240. G7 Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. G7 Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 242. G7 Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 243. G7 Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 244. G7 Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. G7 Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 246. NATO Gene Panel Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. NATO Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. NATO Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 249. NATO Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 250. NATO Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. NATO Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 252. NATO Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 253. NATO Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. NATO Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 255. NATO Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 256. NATO Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 257. NATO Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. NATO Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 259. Global Gene Panel Market Size, by Country, 2017-2032 (USD Million)
TABLE 260. United States Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 261. United States Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. United States Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 263. United States Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 264. United States Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. United States Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 266. United States Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 267. United States Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. United States Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 269. United States Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 270. United States Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 271. United States Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. United States Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 273. Canada Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 274. Canada Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 275. Canada Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 276. Canada Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 277. Canada Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 278. Canada Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 279. Canada Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 280. Canada Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Canada Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 282. Canada Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 283. Canada Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 284. Canada Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Canada Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 286. Mexico Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 287. Mexico Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. Mexico Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 289. Mexico Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 290. Mexico Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 291. Mexico Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 292. Mexico Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 293. Mexico Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. Mexico Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 295. Mexico Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 296. Mexico Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 297. Mexico Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 298. Mexico Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 299. Brazil Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 300. Brazil Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 301. Brazil Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 302. Brazil Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 303. Brazil Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 304. Brazil Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 305. Brazil Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 306. Brazil Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. Brazil Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 308. Brazil Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 309. Brazil Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 310. Brazil Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. Brazil Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 312. United Kingdom Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 313. United Kingdom Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 314. United Kingdom Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 315. United Kingdom Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 316. United Kingdom Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 317. United Kingdom Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 318. United Kingdom Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 319. United Kingdom Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 320. United Kingdom Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 321. United Kingdom Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 322. United Kingdom Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 323. United Kingdom Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. United Kingdom Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 325. Germany Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 326. Germany Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 327. Germany Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 328. Germany Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 329. Germany Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 330. Germany Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 331. Germany Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 332. Germany Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 333. Germany Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 334. Germany Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 335. Germany Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 336. Germany Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 337. Germany Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 338. France Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 339. France Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 340. France Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 341. France Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 342. France Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 343. France Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 344. France Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 345. France Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 346. France Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 347. France Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 348. France Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 349. France Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 350. France Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 351. Russia Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 352. Russia Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 353. Russia Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 354. Russia Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 355. Russia Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 356. Russia Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 357. Russia Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 358. Russia Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 359. Russia Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 360. Russia Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 361. Russia Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 362. Russia Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 363. Russia Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 364. Italy Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 365. Italy Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 366. Italy Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 367. Italy Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 368. Italy Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 369. Italy Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 370. Italy Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 371. Italy Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 372. Italy Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 373. Italy Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 374. Italy Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 375. Italy Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 376. Italy Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 377. Spain Gene Panel Market Size, 2017-2032 (USD Million)
TABLE 378. Spain Gene Panel Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 379. Spain Gene Panel Market Size, by Somatic Gene Panels, 2017-2032 (USD Million)
TABLE 380. Spain Gene Panel Market Size, by Germline Gene Panels, 2017-2032 (USD Million)
TABLE 381. Spain Gene Panel Market Size, by Technology, 2017-2032 (USD Million)
TABLE 382. Spain Gene Panel Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 383. Spain Gene Panel Market Size, by NGS, 2017-2032 (USD Million)
TABLE 384. Spain Gene Panel Market Size, by Application, 2017-2032 (USD Million)
TABLE 385. Spain Gene Panel Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 386. Spain Gene Panel Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 387. Spain Gene Panel Market Size, by Rare Diseases, 2017-2032 (USD Million)
TABLE 388. Spain Gene Panel Market Size, by End User, 2017-2032 (USD Million)
TABLE 389. Spain Gene Panel Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 390. China Gene Panel Market Size, 2017-2032 (USD Millio

Companies Mentioned

  • 10x Genomics, Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Azenta, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Color Health, Inc.
  • Element Biosciences, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Fulgent Genetics, Inc.
  • GeneDx Holdings Corp.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • MedGenome Labs Pvt. Ltd.
  • Merck KGaA
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • NeoGenomics Laboratories, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Related Topics

Related Reports

Gene Panel - Global Strategic Business Report - Product Image

Gene Panel - Global Strategic Business Report

  • Report
  • 239 Pages
  • Global
From
Pan-genomic and Multi-gene Panel Testing Market Size, Share & Trends Analysis Report by Test, Application, End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Pan-genomic and Multi-gene Panel Testing Market Size, Share & Trends Analysis Report by Test, Application, End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Gene Panel Market Report 2026 - Product Image

Gene Panel Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Gene Panel - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Gene Panel - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Gene Panel Reconciliation Services Global Market Report 2026 - Product Image

Gene Panel Reconciliation Services Global Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Gene Panel Market

The Gene Panel market is a subset of the genomics industry that focuses on the development and sale of gene panels. These panels are collections of genes that are used to identify genetic variants associated with a particular disease or condition. They are used in clinical diagnostics, research, and drug development. Gene panels are typically composed of hundreds to thousands of genes, and can be used to detect a wide range of genetic variants. They are often used to identify genetic markers associated with specific diseases, such as cancer, neurological disorders, and cardiovascular diseases. The Gene Panel market is highly competitive, with a number of companies offering different types of panels. Companies in the market include Illumina, Thermo Fisher Scientific, Agilent Technologies, and Qiagen. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.